API Overage: How Much Is Too Much? A Practical Guide by Dosage Form

Overage is additional active ingredient added to a formulation to compensate for expected losses during manufacturing, or for degradation during shelf life, so that the finished product meets its labelled potency. The central question is how much is justified: too little risks a sub-potent batch, and too much can push potency above the upper limit or waste an expensive raw material.

No single percentage applies to all products. The ranges below show how overage varies by dosage form and by the reason it is added. They are a check on a figure under review and do not replace the validated formula or the regulatory filing.

Watch: Calculation of API

Why overage is added

Process-loss overage covers the API lost during manufacturing, such as dust generated during blending, granulation or compression that never reaches a finished unit. It is usually small, often 1-3% for a well-controlled solid dosage process, because a validated process should not lose much API.

Stability/degradation overage compensates for API that degrades over the product's shelf life, so that the tablet still meets its labeled potency at the end of shelf life, not only at release. This is a completely different calculation, driven by real-time and accelerated stability data specific to that API and formulation, and it can range from negligible (a very stable molecule) to substantial (an API known to degrade meaningfully over 24 months). This kind of overage should be backed by actual stability study data, not a rule of thumb.

Many people mix these two up. If someone asks "what overage should I use" without saying which one they mean, they are really asking two different questions.

A regulatory note. ICH Q8(R2) expects any overage in the manufacture of a drug product to be justified in terms of safety and efficacy, and regulators generally look for the process to be optimised so that overage is not used to cover avoidable losses. Treat the ranges below as a sanity check only, and always use the overage approved in your own registered dossier.

Typical ranges by dosage form

Tablets and capsules (solid oral dosage): Process-loss overage is typically low, often 1-3%, since compression and encapsulation are relatively low-loss processes once validated. Stability overage, where applicable, is layered on top and depends entirely on the specific API's degradation profile.

Oral liquids and suspensions: Process overage tends to run a little higher than solids, since liquid manufacturing often involves more transfer steps, line loss, and filling variability. It is also common to see a small fixed-volume overage per container to guarantee the full labeled dose can actually be withdrawn, separate from the potency overage itself.

Parenterals (injectables): Overage practices here are typically the most conservative and the most heavily justified by data, since the margin for error is much smaller and regulatory scrutiny is higher. Both a fill-volume overage (to ensure the full labeled dose is withdrawable, accounting for container and needle holdup) and a potency overage may apply, and both are usually product-specific rather than following a general rule.

Topicals and semisolids: Process loss varies more here because it depends on the equipment (mixing, homogenizing, filling). Overage decisions are often based on that product's own validation batches, not on a general formula.

What overage cannot compensate for

It is not a fix for a process that is out of control. If your granulation reconciliation keeps showing 6-8% loss, do not keep raising the overage. Find out why the process is losing that much material and fix it. Overage should cover normal, expected variation, not hide a process problem.

Do not apply it twice by accident. A common mistake is applying overage once in the target batch quantity and then again in the API requirement calculation, so it is counted twice. Build the overage into the theoretical requirement once, before the assay correction.

Where the assay correction fits in

Once overage is accounted for, there is a second, unrelated correction that also affects how much API you actually weigh out: assay. Raw API rarely arrives at exactly 100% purity, and the certificate of analysis for that specific lot states its actual assay value. The gross weight you dispense needs to be corrected for that purity:

Theoretical (net) API required = Label claim × Batch size × (1 + Overage %)
Gross API to weigh = Theoretical API ÷ (Assay % ÷ 100)

The assay figure should be checked against the current certificate of analysis for the lot being dispensed, since assay varies from lot to lot and an outdated figure changes how much API ends up in the batch.

The API Requirement Calculator applies the overage and the assay correction in this order.